Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation

被引:37
作者
Stauch, Benjamin [2 ]
Hofmann, Henning [3 ]
Perkovic, Mario [3 ]
Weisel, Martin [2 ]
Kopietz, Ferdinand [3 ]
Cichutek, Klaus [3 ]
Muenk, Carsten [1 ]
Schneider, Gisbert [2 ]
机构
[1] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany
[2] Goethe Univ Frankfurt, D-60323 Frankfurt, Germany
[3] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany
关键词
Bioinformatics; immunodeficiency; protein structure; protein-protein interaction; retrovirus; CRYSTAL-STRUCTURE; ENZYME APOBEC3G; PROTEIN; VIRUS; DNA; DOMAIN; HYPERMUTATION; RESTRICTION; DYNAMICS; VIRION;
D O I
10.1073/pnas.0900979106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human APOBEC3 (A3) proteins form part of the intrinsic immunity to retroviruses. Carrying 1 or 2 copies of a cytidine deaminase motif, A3s act by deamination of retroviral genomes during reverse transcription. HIV-1 overcomes this inhibition by the Vif protein, which prevents incorporation of A3 into virions. In this study we modeled and probed the structure of APOBEC3C (A3C), a single-domain A3 with strong antilentiviral activity. The 3-dimensional protein model was used to predict the effect of mutations on antiviral activity, which was tested in a Delta vif simian immunodeficiency virus (SIV) reporter virus assay. We found that A3C activity requires protein dimerization for antiviral activity against SIV. Furthermore, by using a structure-based algorithm for automated pocket extraction, we detected a putative substrate binding pocket of A3C distal from the zinc-coordinating deaminase motif. Mutations in this region diminished antiviral activity by excluding A3C from virions. We found evidence that the small 5.8S RNA specifically binds to this locus and mediates incorporation of A3C into virus particles.
引用
收藏
页码:12079 / 12084
页数:6
相关论文
共 49 条
[31]   Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H [J].
OhAinle, M ;
Kerns, JA ;
Malik, HS ;
Emerman, M .
JOURNAL OF VIROLOGY, 2006, 80 (08) :3853-3862
[32]   Monomeric APOBEC3G is catalytically active and has antiviral activity [J].
Opi, Sandrine ;
Takeuchi, Hiroaki ;
Kao, Sandra ;
Khan, Mohammad A. ;
Miyagi, Eri ;
Goila-Gaur, Ritu ;
Iwatani, Yasumasa ;
Levin, Judith G. ;
Strebel, Klaus .
JOURNAL OF VIROLOGY, 2006, 80 (10) :4673-4682
[33]   Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet [J].
Perkovic, Mario ;
Schmidt, Stanislaw ;
Marino, Daniela ;
Russell, Rebecca A. ;
Stauch, Benjamin ;
Hofmann, Henning ;
Kopietz, Ferdinand ;
Kloke, Bjoern-Philipp ;
Zielonka, Joerg ;
Stroever, Heike ;
Hermle, Johannes ;
Lindemann, Dirk ;
Pathak, Vinay K. ;
Schneider, Gisbert ;
Loechelt, Martin ;
Cichutek, Klaus ;
Muenk, Carsten .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (09) :5819-5826
[34]   The APOBEC-2 crystal structure and functional implications for the deaminase AID [J].
Prochnow, Courtney ;
Bransteitter, Ronda ;
Klein, Michael G. ;
Goodman, Myron F. ;
Chen, Xiaojiang S. .
NATURE, 2007, 445 (7126) :447-451
[35]   Twilight zone of protein sequence alignments [J].
Rost, B .
PROTEIN ENGINEERING, 1999, 12 (02) :85-94
[36]   COMPARATIVE PROTEIN MODELING BY SATISFACTION OF SPATIAL RESTRAINTS [J].
SALI, A ;
BLUNDELL, TL .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 234 (03) :779-815
[37]   The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif [J].
Sheehy, AM ;
Gaddis, NC ;
Malim, MH .
NATURE MEDICINE, 2003, 9 (11) :1404-1407
[38]   Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein [J].
Sheehy, AM ;
Gaddis, NC ;
Choi, JD ;
Malim, MH .
NATURE, 2002, 418 (6898) :646-650
[39]   The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity [J].
Shindo, K ;
Takaori-Kondo, A ;
Kobayashi, M ;
Abudu, A ;
Fukunaga, K ;
Uchiyama, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44412-44416
[40]   ABERRANT GAG PROTEIN-COMPOSITION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF MUTANT - PRODUCED IN PRIMARY LYMPHOCYTES [J].
SIMM, M ;
SHAHABUDDIN, M ;
CHAO, W ;
ALLAN, JS ;
VOLSKY, DJ .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4582-4586